Becton, Dickinson and Company

Financials

Cash from operating activities 3.54 B4.65 B2.63 B2.99 B3.8 B3.43 B 3.39 B Cash from investing activities -1.23 B-1.88 B-3.23 B-716 M-5.51 B-818 M -1.21 B Cash from financing activities 22 M-3.31 B-591 M-1.96 B2.09 B-3.62 B -1.99 B Free cash flow 2.73 B3.42 B1.66 B2.12 B3.07 B2.67 B 2.63 B

Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas. BD is ranked #211 in the 2024 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2023.

BDX

Financials

Becton, Dickinson and Company

Haberler

BD Files for CE Mark of Liverty TIPS Stent for Portal Hypertension

BD Unveils HemoSphere Stream for Continuous Noninvasive BP Monitoring

BD’nin Liverty TIPS stent greftine Avrupa’da CE onayı

ClearBridge Dividend Strategy Q1 2026 Portfolio Positioning

Dividend Champion, Contender, And Challenger Highlights: Week Of March 29

Argus, piyasa çalkantısı nedeniyle Becton Dickinson hisse hedefini düşürdü

Best Dividend Aristocrats As Of March 20, 2026

Best Dividend Kings: March 2026

Should You Hold or Sell HOLX Stock as It Nears the End of Public Phase?

Waters Corporation, satın aldığı SpinCo işletmesi için mali tablolar sundu

Tıbbi teknoloji fiyatlandırması kısa pozitif trendden sonra sabit seyrediyor

Med Tech pricing turns flat after brief positive trend, says Raymond James